Elisabetta Castoldi

Johannes Gutenberg University Mainz — Germany

Medicine · Health Sciences

36h-index4.1kcitations119works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Blood Coagulation and Thrombosis Mechanisms(96), Hemophilia Treatment and Research(58), Coagulation, Bradykinin, Polyphosphates, and Angioedema(30), Venous Thromboembolism Diagnosis and Management(27), Platelet Disorders and Treatments(17)

Publications119 total

Thrombophilia
2026
A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor
Blood·2025· 3 cited
Thrombophilic thrombomodulin variants
Blood·2025· 1 citedOpen Access
Tissue Factor Pathway Inhibitor Modulates Endothelial and Vascular Smooth Muscle Cell Functions By Drifting Cellular Phenotypes
Blood·2024Open Access
Case Report: Laboratory detection of a thrombotic tendency in a family with hypodysfibrinogenemia and a novel FGG mutation
Frontiers in Cardiovascular Medicine·2024Open Access
Plasma levels of complement components C5 and C9 are associated with thrombin generation
Journal of Thrombosis and Haemostasis·2024· 3 citedOpen Access
Factor V variants in bleeding and thrombosis
Research and Practice in Thrombosis and Haemostasis·2024· 11 citedOpen Access
Evaluation of Innovative Laboratory Tests to Predict a Thrombotic Phenotype in a Family with Dysfibrinogenemia and a Novel <i>FGG</i> Mutation
Blood·2023Open Access
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency
Journal of Thrombosis and Haemostasis·2023· 7 citedOpen Access
PB0214 Evaluation of Innovative Laboratory Tests to Predict a Thrombotic Phenotype in a Family with Dysfibrinogenemia and a Novel FGG Mutation
Research and Practice in Thrombosis and Haemostasis·2023Open Access
OC 35.1 Response of Thrombin Generation to Rivaroxaban in Twin-Families: Influence of Sex and Contraceptives
Research and Practice in Thrombosis and Haemostasis·2023· 1 citedOpen Access
OC 07.3 In vitro and ex vivo Rescue of a Nonsense Mutation (F5 p.Arg1161Ter) Responsible for Severe Coagulation Factor V Deficiency
Research and Practice in Thrombosis and Haemostasis·2023Open Access
PB1424 PCF11 is a Central Hub in the Regulation of Inflammation in an Animal Model of Septicemia
Research and Practice in Thrombosis and Haemostasis·2023Open Access
PB1136 Improving Genetic Testing for Antithrombin Deficiency by Optimizing ACMG/AMP Variant Curation Guidelines for the SERPINC1 Gene
Research and Practice in Thrombosis and Haemostasis·2023Open Access
PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.
HemaSphere·2023Open Access
Making sense of FV short
Blood·2023Open Access
Post-transcriptional control of haemostatic genes: mechanisms and emerging therapeutic concepts in thrombo-inflammatory disorders
Cardiovascular Research·2023· 14 citedOpen Access
Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee
Journal of Thrombosis and Haemostasis·2023· 21 citedOpen Access
A Novel Quali-Quantitative Defect of VWF
Blood·2021· 1 cited
Antisense-Mediated Down-Regulation of Factor V-Short Splicing in a Liver Cell Line Model
Applied Sciences·2021· 3 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Jan Rosing(25), Paolo Simioni(17), Francesco Bernardi(14), Barbara Lunghi(14), Tilman M. Hackeng(11), Guido Tans(9), Luca Spiezia(7), Daniela Tormene(7), Connie Duckers(6), Giancarlo Castaman(5), Domenico Girelli(5), Federico Mingozzi(5), Henri M.H. Spronk(4), Hugo Ten Cate(4), Giovanna Marchetti(4), Sabrina Gavasso(4), L.F.A. Maurissen(4), P. Ferraresi(3), Claudia Maria Radu(3), Donato Gemmati(3)